TLDR
- A pair of Conagra directors acquired 42,500 shares collectively on April 14, investing approximately $609,000 with the stock trading close to its annual bottom.
- Shares have declined 17% year-to-date in 2026, pressured by volume declines, shrinking margins, and reduced full-year guidance.
- Third-quarter results disappointed with earnings per share of $0.39 versus expectations of $0.40 and sales declining 1.9% compared to the prior year.
- Morgan Stanley reduced its price objective to $15 from $17 this Thursday while maintaining an “equal weight” stance.
- The consensus among analysts stands at “Reduce” with a mean price target of $15.80 — comprising 1 Buy, 13 Hold, and 4 Sell recommendations.
Two members of Conagra’s board recently demonstrated their confidence by making substantial share purchases. On April 14, Director Richard H. Lenny acquired 25,000 CAG shares at $14.34 apiece, totaling $358,500. That same day, Director John J. Mulligan scooped up 17,500 shares at $14.31 each, spending $250,425.
Their collective investment of approximately $609,000 occurred while shares traded near the 12-month low of $14.04. Mulligan’s transaction increased his stake in the company by 542%. Following his purchase, Lenny’s holdings now total 229,340 units with a market value approaching $3.3 million.
The context surrounding these purchases is significant. CAG’s recent selloff accelerated on April 9 following BNP Paribas’ downgrade from Outperform to Neutral, accompanied by a price target reduction from $19 to $16. Shares closed beneath $16 that very day.
The challenges intensified shortly after. Conagra announced John Brase as its incoming CEO and president on April 13. Jefferies noted that Brase would inherit “high leverage, ongoing inflationary pressures, and margin compression.”
Disappointing Quarterly Results Compound Concerns
Earlier in April, Conagra released fiscal third-quarter financials that fell short of Wall Street projections. The packaged foods giant delivered earnings per share of $0.39, missing the consensus estimate of $0.40 by one cent. Sales reached $2.79 billion, marginally surpassing the anticipated $2.76 billion.
However, the modest revenue beat provided little comfort. Total sales slipped 1.9% from the year-ago period, while earnings per share of $0.51 in the comparable quarter last year highlighted a substantial decline. The company also lowered its full fiscal year forecast, citing challenging macroeconomic conditions and sustained inflationary headwinds.
Year-to-date, the stock has tumbled 17%. By comparison, the S&P 500 has gained 4.2% during the same timeframe.
Wall Street Maintains Bearish Posture
Analyst sentiment remains decidedly cautious. This Thursday, Morgan Stanley trimmed its price target on CAG from $17 to $15 while retaining an “equal weight” rating. That new target suggests merely 3.6% potential upside from Wednesday’s closing price.
Morgan Stanley joins a chorus of downgrades. JPMorgan lowered its target from $19 to $17 in March. TD Cowen and Deutsche Bank both adjusted their targets down to $14. Stifel made a similar reduction to $15 this week.
According to MarketBeat’s current analyst compilation, CAG carries 1 Buy rating, 13 Hold ratings, and 4 Sell ratings, with a consensus price target of $15.80 and an overall “Reduce” recommendation.
CAG started Thursday’s session at $14.49. The stock’s 50-day moving average stands at $16.75, while the 200-day moving average rests at $17.38, both substantially above current trading levels.
One notable metric: CAG presently offers approximately a 9% dividend yield, representing the highest yield among S&P 500 constituents. The average dividend yield for payers within the index is 2.3%.
Institutional ownership comprises 83.75% of outstanding shares. A handful of smaller investment funds expanded their positions during recent quarters, although the increases were relatively minor in scale.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
